| Gene ID | 6502 |
| Symbol | SKP2 |
| Synonymous | FBL1|FBXL1|FLB1|p45 |
| Full name | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
| Gene description | CDK2/cyclin A-associated protein p45|F-box/LRR-repeat protein 1|S-phase kinase-associated protein 2|S-phase kinase-associated protein 2 (p45)|p45skp2 |
| Cytoband | 5p13 |
| Gene type | protein-coding |
| Synonymous | MIM:601436; HGNC:HGNC:10901; Ensembl:ENSG00000145604; HPRD:03256; Vega:OTTHUMG00000131106 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Regulation of retinoblastoma protein;PID Curated;200191 |
Pathway | p53 pathway;PID Curated;200175 |
Pathway | Small cell lung cancer;KEGG PATHWAY;hsa05222 |
Pathway | e2f1 destruction pathway;PID BioCarta;100034 |
Pathway | Ubiquitin mediated proteolysis;KEGG PATHWAY;hsa04120 |
Pathway | Cell Cycle, Mitotic;Reactome;REACT:152 |
Pathway | FoxO family signaling;PID Curated;200091 |
Pathway | Cell cycle;KEGG PATHWAY;hsa04110 |
Pathway | Notch signaling pathway;PID Curated;200013 |
Pathway | cell cycle: g1/s check point;PID BioCarta;100160 |
Pathway | FOXM1 transcription factor network;PID Curated;200120 |
Pathway | C-MYC pathway;PID Curated;200093 |
Pathway | Pathways in cancer;KEGG PATHWAY;hsa05200 |
Pathway | regulation of p27 phosphorylation during cell cycle progression;PID BioCarta;100087 |
Disease | Cancer;FunDO |
Disease | Skin disease;FunDO |
Sequence Information | |
|---|---|
Nucleotide Sequence | >6502 : length: 3520 AATTCCCAGCAGGCCTTGGGCCTCAGTGCGGCCGCGAAGCAGAGCGGGCTGTAGAGCCTTGCGCGCGCAGTGGGGATGGAACGTTGCTAGGCTTAGCGGGTCTGGCTGCTGGGGGCCCGA GCAGCACGCTCGGAGCCGCCGCGCGCCAAAGCGGGAATCTGGGAGGCGAGCAGCTCTGCAGTTAATGCACGTATTTTAAACTCCCGGGCCTGCGGACGCTATGCACAGGAAGCACCTCCA GGAGATTCCAGACCTGAGTAGCAACGTTGCCACCAGCTTCACGTGGGGATGGGATTCCAGCAAGACTTCTGAACTGCTGTCAGGCATGGGGGTCTCCGCCCTGGAGAAAGAGGAGCCCGA CAGTGAGAACATCCCCCAGGAACTGCTCTCAAACCTGGGCCACCCGGAGAGCCCCCCACGGAAACGGCTGAAGAGCAAAGGGAGTGACAAAGACTTTGTGATTGTCCGCAGGCCTAAGCT AAATCGAGAGAACTTTCCAGGTGTTTCATGGGACTCCCTTCCGGATGAGCTGCTCTTGGGAATCTTTTCCTGTCTGTGCCTCCCTGAGCTGCTAAAGGTCTCTGGTGTTTGTAAGAGGTG GTATCGCCTAGCGTCTGATGAGTCTCTATGGCAGACCTTAGACCTCACAGGTAAAAATCTGCACCCGGATGTGACTGGTCGGTTGCTGTCTCAAGGGGTGATTGCCTTCCGCTGCCCACG ATCATTTATGGACCAACCATTGGCTGAACATTTCAGCCCTTTTCGTGTACAGCACATGGACCTATCGAACTCAGTTATAGAAGTGTCCACCCTCCACGGCATACTGTCTCAGTGTTCCAA GTTGCAGAATCTAAGCCTGGAAGGCCTGCGGCTTTCGGATCCCATTGTCAATACTCTCGCAAAAAACTCAAATTTAGTGCGACTTAACCTTTCTGGGTGTTCTGGATTCTCTGAATTTGC CCTGCAGACTTTGCTAAGCAGCTGTTCCAGACTGGATGAGCTGAACCTCTCCTGGTGTTTTGATTTCACTGAAAAGCATGTACAGGTGGCTGTTGCGCATGTGTCAGAGACCATCACCCA GCTGAATCTTAGCGGCTACAGAAAGAATCTCCAGAAATCAGATCTCTCTACTTTAGTTAGAAGATGCCCCAATCTTGTCCATCTAGACTTAAGTGATAGTGTCATGCTAAAGAATGACTG CTTTCAGGAATTTTTCCAGCTCAACTACCTCCAACACCTATCACTCAGTCGGTGCTATGATATAATACCTGAAACTTTACTTGAACTTGGAGAAATTCCCACACTAAAAACACTACAAGT TTTTGGAATCGTGCCAGATGGTACCCTTCAACTGTTAAAGGAAGCCCTTCCTCATCTACAGATTAATTGCTCCCATTTCACCACCATTGCCAGGCCAACTATTGGCAACAAAAAGAACCA GGAGATATGGGGCATCAAATGCCGACTGACACTGCAAAAGCCCAGTTGTCTATGAAGTATTTATTGCAGGATGGTGTCTCTTCTTTAGAACAGGGAAAATAGGCAGGAAGCCCAATTGCT GGAGTACTTAGCTAGTTTTATTCTTGGTTTTCCCTTTGCCTTCATTCTGCAAGTATACTAGGGAGCCATTTGAGAGGGAAAACTATGAAATCTTGCTTTTTGAAATGATTCTAAAAGCTT CTATCACTGCTTTGCTCTTAAGAGCCAAAGTTGTAGGCCTTTTGAAATTTTAGGAGAGTGAGCCTATAATTTCAAGATACCTTAAAGAGCAAAATTTGAGCCACCTCTTCCAAGTGCCCT TCTTACTAAGTCTATTCAGAATCAAGCTTAAAAATTACCACCAGCAAACAATCTTCATAGCCCATATAACTTTTATCTATTTAATTTTATAGTATTGCTTTATAAGACAGCTTAGAAGAA CAATAAGCTATTTGTATTATGAGCTGAACAAAAAGAGAATCATAGGATAGTAGCGTCTGAGGCCATCTTTTCTAGGAATAGGAAAGAGAAAAATGTATTTGAATTTTGCCTTTAGATTTG AAATTAGGTTAATAGAAATAAGTAACCCCATGTAATTCACCTTAAAACTTAACAAAAGACCAAACATTACAAAACCCAGAGATATAGAATCAATATAGGATTTGAAGGCCCAGCAGACAG TTTTCTATGACAGGTTAATCTGAAGTATCCTGTAATGTTCATTAAGTTACTGTGTTTCCAGAATCTAAATTAGATGAGAAATATAATTGTGGTTTTCTAACTTGATAATCAAATTATGTT AACATGGGTCCTTTAGCTTTTAAAATGACTTGCTTTGTTTTAGAAAGGTGGTATTAATCCACTCTCTATTCTTGAAAATTTGGATGGGAGAATTCTGAAGTTGCCTGCTGTTTTCCTTTA GCGCTGAGGTTCTTAAGGTTACTTTTATATTACTCTGGAATCAAGTATTTTAAATTGTATTTTTTTTTTAAATGATCTCTCAGCAATAATTGTTTGAAACTATCCATATATAAGGTTATC AGACCTACAGTTCCCTAAGAGGAACTGCATGTTCTCTTCAATCAGAAATATACAGTAGAAGCAGGTATATCTTCCATGCAGTTTCAGTAGTAAGCACTACTTATACCTACATAAGAGTTA AAATCCAGATGTGGGACCTTTTGATACCATCAGTGATATATATTTTTTTAAACTGGTACAGAGAAGTGAAAAGATTAAATTCTACTTCTATTTTTTTTTTTTTTTTTTGAGACGGAGTCT CGCTCTGTCACCAAGGCCGGAGTGCAGTGGTGCGATCTCGGCTCACTGCAAGCTCCGCCTCCCAGGTTCACGTCATTCTCCTGCCTCAGCCTCCCGACTAGCTGGGACTACAGGCGCCCA CCACCACGCCCGGCTAATTTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTAGCCAGGATGGTCTCAATCTCCTGACCTCATGATCCGCCCGTCTTGGCCTCCCAAAGTGCTGG GATTACAGGCATGAGCAACTGCGCCCAGCCAAATTCTACTTCTTAAAAATCACAAAAACTAGTTTAAATTGATGACTTGTTCGTATGTTCAAAATGTAACAACAAAAAAAGCTAACACCA GTCATTTATATTAACTTTTTTTTTTTAAATCAAAAATTGTTAATGTTAGAAACATACTATGAAGTGCCTTTATCTGCTTAGACCTAAGGAAGATTTTAAAGTTGGGTTGCACAGGAAATG ATGATGCTTCAATTTCTTAATAGTTAAAAAGTGCTAAATACTACTTGAAATTATTGTTTACAGATTAGTGACAAGAGCTGGGGTTAGGATCCGGTTGGACTCTGACATCGGATGCCCTCA AACATACAGAACTTCCAAACTCAAGTCCAGCCATAAGCTATTTTGCCAACATGTCAGAGTAATCTGTATTTTTGTATGTGATTTCTACTTTTATAGACTTGTTTTAAAACAATAAAACAC ATTTTTATAAAAATGAGTGCTTAAAAAAAAAAAAAAAAAA |
Protein Sequence | >6502 : length: 424 MHRKHLQEIPDLSSNVATSFTWGWDSSKTSELLSGMGVSALEKEEPDSENIPQELLSNLGHPESPPRKRLKSKGSDKDFVIVRRPKLNRENFPGVSWDSLPDELLLGIFSCLCLPELLKV SGVCKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP TLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRLTLQKPSCL |